CME: Bleeding Disorders & Female Patients: Optimizing Care in Women’s Health Settings

Bleeding Disorders & Female Patients: Optimizing Care in Women’s Health Settings

Bleeding Disorders & Female Patients: Optimizing Care in Women’s Health Settings
Review two patient cases on bleeding disorders that demonstrate the important role of women’s healthcare providers in management.

Available credits: 0.25

Time to complete: 15 Minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Women with bleeding disorders, including hemophilia carriers and those with Von Willebrand disease (VWD), or VWD are disproportionately affected by bleeding when compared to men, largely due to menstruation and pregnancy.  In this CME activity, discover how women’s healthcare providers can make a significant impact in these patients’ lives by facilitating early identification, beginning management, and working with a multidisciplinary team to ultimately provide the best care to our patients. 
    Dr. Andrea Singer welcomes Dr. Ayesha Zia to discuss these cases and more.

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. 

    Andrea J. Singer, MD, FACP, CCD
    Director, Women's Primary Care
    Director, Bone Densitometry
    Department of Obstetrics and Gynecology
    MedStar Georgetown University Hospital
    Washington, DC
    Dr. Singer receives consulting fees from Agnovos, Amgen, Eli Lilly, Merit, Radius, TherapeuticsMD, and UCB and is a speaker for Amgen, Eli Lilly, and Radius.

    Ayesha Zia, MD
    Assistant Professor of Pediatrics
    Division of Hematology Oncology
    University of Texas Southwestern
    Children’s Medical Center
    Dallas, TX 
    Dr. Zia conducts contracted research with Shire Pharmaceuticals.

    Reviewers/Content Planners/Authors: 

    • Stephen Chavez has nothing to disclose. 
    • Christa Dardaganian has nothing to disclose.
    • Kahlil Demonbreun, DNP, RNC-OB, WHNP-BC, ANP-BC, FAANP receives consulting fees from Hologic and Symbiomix Therapeutics.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Jessica McGrory has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
  • Learning Objectives

    The goal of this activity is to enable effective collaboration and communication between the members of the professional teams who care for female patients suspected of having bleeding disorders.  After participating in this educational activity, participants should be better able to:

    • Identify signs and symptoms that raise suspicion of a bleeding disorder to promptly refer for, or implement, management strategies.
    • Incorporate evidence-based, multidisciplinary, and interprofessional management strategies for female patients with bleeding disorders, particularly menorrhagia and disorders during pregnancy and childbirth, to optimize safety.
  • Target Audience

    This activity is designed to meet the educational needs of obstetricians and gynecologists, primary care physicians, family practitioners and other members of the interprofessional team who are involved in the management of female patients suspected of having bleeding disorders.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider(s)/Educational Partner(s)

    Omnia Education has a core focus on women's health and the ways in which diseases and conditions impact the female patient. That unique focus has transformed the CME learning environment for healthcare professionals nationwide. We impact thousands of clinicians annually, many of whom return each year for clinical updates and connectivity with regional peers.

  • Commercial Support

    This activity is supported by an independent educational grant from Novo Nordisk Inc.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments


We’re glad to see you’re enjoying Medtelligence…
but how about a more personalized experience?

Register for free